Related Experiment Video
Updated: May 28, 2026

Povidone Iodine Rectal Preparation at Time of Prostate Needle Biopsy is a Simple and Reproducible Means to Reduce Risk of Procedural Infection
Published on: September 21, 2015
Transrectal ultrasound-guided prostate biopsies in patients taking aspirin for cardiovascular disease: A
Luca Carmignani1, Stefano Picozzi, Giorgio Bozzini
1Urology Department, University of Milan, IRCCS Policlinico San Donato, San Donato Milanese, Italy.
Insights
Continuing aspirin therapy does not increase bleeding risks after prostate biopsies. Stopping aspirin before these procedures is unnecessary, ensuring continued cardiovascular protection for patients.
Area of Science:
- Urology
- Cardiovascular Medicine
- Pharmacology
Background:
- Managing anti-platelet therapy peri-operatively presents a dilemma between bleeding risk and cardiovascular protection.
- The decision to stop aspirin before procedures impacts patient safety and outcomes.
Purpose of the Study:
- To determine if continued aspirin therapy is a risk factor for bleeding complications after ultrasound-guided prostate biopsy.
- To analyze the association between aspirin use and hemorrhagic events in this context.
Main Methods:
- Systematic review and meta-analysis of studies from January 1990 to May 2011.
- Inclusion of bibliographic searches in PubMed, MEDLINE, and EMBASE, plus author's own series.
- Analysis of 3218 participants to assess bleeding risks associated with aspirin.
Main Results:
- Aspirin use was associated with a statistically significant increase in haematuria (OR 1.36, P=0.001), but this was primarily minor bleeding.
- No statistically significant increase in rectal bleeding (OR 1.24, P=0.33) or haematospermia (OR 1.52, P=0.24) was observed.
- The overall risk of moderate and severe bleeding complications was not elevated.
Conclusions:
- Continued aspirin use does not significantly increase the risk of overall bleeding or moderate/severe haematuria post-prostate biopsy.
- Stopping aspirin before transrectal ultrasound-guided prostate biopsy is generally unnecessary.
- This comprehensive analysis provides evidence supporting the continuation of aspirin therapy.
Introduction:
The management of anti-platelet therapy in the peri-operative period is a source of great concern. The dilemma is between whether to stop these agents peri-operatively in order to reduce the risk of bleeding complications, or to continue them in order not to compromise the protection they afford against the risk of cardiovascular events.
Materials And Methods:
The aim of this systematic review and meta-analysis was to understand whether continued aspirin therapy is a risk factor for bleeding complications after ultrasound-guided biopsy of the prostate. A bibliographic search covering the period from January 1990 to May 2011 was conducted in PubMed, MEDLINE and EMBASE. We also included our own series in the analysis.
Results:
A total of 3218 participants were included. Haematuria was statistically more frequent (P=0.001) among patients taking aspirin than in the control group with an odds ratio estimate of 1.36 [1.13;1.64]. This increased risk was, however, due to minor bleeding. The occurrence of rectal bleeding and haematospermia was not statistically increased (P=0.33 and P=0.24, respectively) in patients taking aspirin compared to in the control group with odds ratios estimate of 1.24 [0.80;1.93] and 1.52 [0.75;3.08], respectively.
Discussion:
There is limited information of the relationship between continued use of aspirin and haemorrhagic complications after transrectal ultrasound-guided biopsy of the prostate. This is the first comprehensive analysis on this topic.
Conclusion:
Continued use of aspirin does not increase the risk of overall bleeding or moderate and severe haematuria after prostatic biopsy, and thus stopping aspirin before such biopsies is unnecessary.
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Atherosclerosis III: Management
Imaging Studies for Cardiovascular System V: CT
Peripheral Artery Disease III: Interprofessional Care
